FrancophonIA/ELRC3.0 huggingface dataset:
English: In mildly impaired patients, the dose should not exceed 30 mg.
Slovenian: Pri bolnikih z blago okvarjenim delovanjem jeter odmerek ne sme preseči 30 mg.
English: Pharmacokinetic Properties
Slovenian: Farmakodinamične lastnosti
English: hepatitis, icterus and interstitial nephritis.
Slovenian: Povečanje ravni jetrnih encimov hepatitis, ikterus in intersticialni nefritis.
English: Matsukawa et al evaluated in an uncontrolled study the efficacy of lansoprazole 15 mg and 30
Slovenian: Matsukawa et al so v nekontrolirani raziskavi ovrednotili učinkovitost lansoprazola 15 mg in 30 mg pri 47 bolnikih z razjedami želodca ali dvanajstnika, ki so bile povzročene z NSAID.
English: Absorption and distribution: Lansoprazole is rapidly inactivated by gastric acid and lansoprazole is consequently administered as enteric coated granules in gelatin capsules.
Slovenian: Želodčna kislina hitro inaktivira lansoprazol, ki se zato daje v obliki granul z enterično oblogo v želatinastih kapsulah.
English: • Treatment of benign gastric and duodenal ulcers associated with the use of anti-inflammatory analgesics in patients requiring continued anti-inflammatory analgesic treatment.
Slovenian: • Zdravljenje benignih razjed dvanajstnika in želodca, povezanih z uporabo protivnetnih analgetikov pri bolnikih, pri katerih je potrebno neprekinjeno zdravljenje s protivnetnimi analgetiki.
English: Posology and Method of Administration
Slovenian: Odmerjanje in način uporabe
English: The bibliographic data submitted by the applicant show that in patients who continue to receive NSAID medication, lansoprazole is more effective in healing gastric ulcers than H2-receptor antagonist and the healing rates are acceptable although somewhat lower than reported for omeprazole.
Slovenian: NSAID, lansoprazol učinkovitejši pri celjenju želodčnih razjed kot zaviralec receptorjev H2 ter da so hitrosti celjenja sprejemljive, čeprav nekoliko manjše od hitrosti, ki se navaja za omeprazol.
English: Care should be exercised in the administration of lansoprazole in patients with mildly to moderately impaired hepatic function.
Slovenian: Pri uporabi lansoprazola pri bolnikih z blago do zmerno okvarjenim delovanjem jeter je treba biti previden.
English: The bibliographic data submitted provide evidence to support the indications:
Slovenian: Bibliografski podatki, ki jih je predložil vlagatelj, kažejo, da je pri bolnikih, ki še naprej jemljejo
English: D-83607 Holzkirchen Lansohexal 30 mg - Hartkapseln 30 mg
Slovenian: D-83607 Holzkirchen Lansohexal 30 mg - Hartkapseln 30 mg Gastrorezistentna kapsula, trda Peroralna uporaba
English: drowsiness, depression,
Slovenian: depresija,
English: Lansohexal 15 mg - Hartkapseln 15 mg
Slovenian: Lansohexal 15 mg - Hartkapseln 15 mg Gastrorezistentna kapsula, trda Peroralna uporaba
English: GROUNDS FOR AMENDMENT OF THE SUMMARY OF PRODUCT CHARACTERISTICS
Slovenian: RAZLOGI ZA DOPOLNILO POVZETKA GLAVNIH ZNAČILNOSTI ZDRAVILA
English: The lansoprazole dose should therefore be taken at least an hour prior or after.
Slovenian: Antacidi in sukralfat lahko zmanjšajo biološko razpoložljivost lansoprazola, zato je treba odmerek lansoprazola vzeti vsaj eno uro prej ali pozneje.
English: bronchial constriction, impotence and angioedema.
Slovenian: impotenca in angioedem.
English: confusion, vertigo and paresthesia, somnolence, tremor.
Slovenian: vrtoglavica nemir, insomnija, dremavost,
English: fever, hyperhidrosis,
Slovenian: povečana telesna temperatura, hiperhidroza, bronhialna konstrikcija,
English: Gastro-resistant capsule, hard Oral use
Slovenian: 30 mg Gastrorezistentna kapsula, trda Peroralna uporaba
English: • Prophylaxis of gastric and duodenal ulcer associated with the use of anti-inflammatory agents and relief of symptoms in patients requiring continuous anti-inflammatory therapy
Slovenian: • Zdravljenje razjed želodca in dvanajstnika, povezanih z uporabo protivnetnih zdravil, in lajšanje simptomov pri bolnikih, pri katerih je potrebno neprekinjeno zdravljenje s protivnetnimi zdravili.
English: Preclinical Safety Data
Slovenian: Posebna navodila za shranjevanje
English: Patients with healed ulcers and H. pylori eradicated then received naproxen 750 mg daily and were randomized to receive either lansoprazole 30 mg or no treatment for 8 weeks.
Slovenian: 750 mg in bili za 8 tednov naključno razporejeni v skupino, ki je prejemala lansoprazol 30 mg ali skupino brez zdravljenja.
English: • Prophylaxis of NSAID-associated gastric and duodenal ulcer in patients at risk requiring continuous NSAID-treatment
Slovenian: • Zdravljenje benignih razjed dvanajstnika in želodca, povezanih z NSAID, pri bolnikih, pri katerih obstaja tveganje, da bo potrebno neprekinjeno zdravljenje z NSAID.
English: Lansocid
Slovenian: Smukec
English: Candidiasis of oesophagus,
Slovenian: glositis, kandidiaza ezofagusa,
English: Lansohexal 15 mg Hartkapseln 15 mg
Slovenian: Lansoprazol HEXAL 15mg 15 mg Gastrorezistentna kapsula, trda Peroralna uporaba
English: MARKETING AUTHORISATION HOLDER [To be completed nationally]
Slovenian: IMETNIK DOVOLJENJA ZA PROMET Z ZDRAVILOM [Podatke je treba dopolniti v posameznih državah] 8.
English: Patients received eradication treatment followed by lansoprazole 30 mg for 4 weeks.
Slovenian: Bolniki so bili podvrženi eradikacijskemu zdravljenju, čemur je sledilo 4-tedensko jemanje lansoprazola 30 mg. Bolniki z zaceljenimi razjedami in odstranjeno H. pylori so nato dnevno prejemali naproksen
English: Prophylaxis of NSAID-associated gastric and duodenal ulcers in patients requiring continuous NSAIDtreatment:
Slovenian: Profilaksa benignih razjed dvanajstnika in želodca, povezanih z NSAID, pri bolnikih, pri katerih je potrebno neprekinjeno zdravljenje z NSAID: 15 mg enkrat dnevno.
English: Benign NSAID-associated gastric and duodenal ulcers:
Slovenian: Benigne razjede želodca in dvanajstnika, povezane z NSAID:
English: Digoxin
Slovenian: NSAID.
English: Treatment of gastric ulcer:
Slovenian: Učinek na izločanje želodčne kisline:
English: insomnia,
Slovenian: zmedenost,
English: Invented name Strength
Slovenian: Zaščiteno ime Jakost
English: 1 litre
Slovenian: 1 liter
English: Packaging Content Package size
Slovenian: Način uporabe Pakiranje vsebina Velikost pakiranja
English: Bottle (glass type III)
Slovenian: 4 litri steklenica (steklo tip III)
English: In the MRP United Kingdom is the Reference Member State (RMS) and Austria, Belgium, Denmark, Finland, France, Greece, Germany, Italy, Ireland, Iceland, Luxembourg, The Netherlands, Portugal, Spain and Sweden are Concerned Member States (CMS).
Slovenian: V postopku medsebojnega priznavanja je bilo Združeno kraljestvo referenčna država članica, medtem ko so bile Avstrija, Belgija, Danska, Finska, Francija, Grčija, Nemčija, Italija, Irska, Islandija, Luksemburg, Nizozemska, Portugalska, Španija in Švedska zadevne države članice.
English: SERETIDE EVOHALER and associated names (See Annex I)
Slovenian: SERETIDE EVOHALER in z njim povezana imena (glejte Dodatek I)
English: In several EU Member States Seretide Evohaler and associated names are approved through the Mutual Recognition Procedure (MRP).
Slovenian: V številnih državah članicah EU je bilo zdravilo Seretide Evohaler in z njim povezana imena odobreno s postopkom medsebojnega priznavanja (MRP).
English: Seretide Evohaler and associated names (see Annex I) contain salmeterol and fluticasone propionate, a fixed dose combination of the long acting β-agonist salmeterol and the inhaled corticosteroid fluticasone propionate and is indicated for the regular treatment of asthma where use of a combination product (long-acting beta-2-agonist and inhaled corticosteroid) is appropriate: - patients not adequately controlled with inhaled corticosteroids and ‘as needed' inhaled short acting beta-2-agonist or - patients already adequately controlled on both inhaled corticosteroid and long-acting beta-2-agonist.
Slovenian: Zdravilo Sertide Evohaler in z njim povezana imena (glejte Dodatek I), ki vsebuje salmeterol in flutikazon propionat, kombinacijo fiksnih odmerkov dolgo delujočega β-agonista (LABA) salmeterola in inhalacijskega kortikosteroida (ICS) flutikazon propionata (FP), je indicirano za običajno zdravljenje astme, kadar je uporaba kombiniranega zdravila (dolgo delujočega beta-2-agonista in inhalacijskega kortikosteroida) ustrezna: pri bolnikih, pri katerih z inhalacijskimi kortikosteroidi in »po potrebi« z inhalacijskim kratko delujočim beta-2-agonistom ni mogoče doseči zadostnega nadzora bolezni, ali pri bolnikih, pri katerih je bilo mogoče že z inhalacijskimi kortikosteroidi in dolgo delujočim beta-2-agonistom vzpostaviti zadosten nadzor bolezni.
English: This may happen:
Slovenian: To se lahko zgodi:
English: • If you are under 18 or over 75 years of age.
Slovenian: • če ste mlajši od 18 ali starejši od 75 let.
English: The expiry date refers to the last date of that month.
Slovenian: Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: Prandin may not be suitable for you.
Slovenian: Prandin pri vas morda ni primerno.
English: • If you are about to have major surgery or you have recently suffered a severe illness or infection.
Slovenian: • če imate predvideno večjo operacijo ali ste pred kratkim preboleli hudo bolezen ali okužbo.
English: Date of last renewal: 23 July 2008
Slovenian: Datum zadnjega podaljšanja: 23. julij 2008
English: No safety concerns were raised.
Slovenian: Ugotovili niso nobenih težav z varnostjo.
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 29 January 2001
Slovenian: DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Datum prve odobritve: 29. januar 2001
English: • Diabetic ketoacidosis, with or without coma.
Slovenian: • Diabetična ketoacidoza s komo ali brez nje.
English: The safety and efficacy of repaglinide in children below 18 years have not been established.
Slovenian: Pediatrična populacija Varnost in učinkovitost repaglinida pri otrocih, mlajših od 18 let, še nista bili dokazani.
English: In case a Risk Management Plan is submitted to any regulatory authority the MAH must inform the Rapporteur.
Slovenian: Če se načrt za obvladovanje tveganja (RMP) predloži kateremu koli regulatornemu organu, mora imetnik dovoljenja za promet z zdravilom o tem obvestiti poročevalca.
English: What Prandin is and what it is used for
Slovenian: Kaj je zdravilo Prandin in za kaj ga uporabljamo
English: Talk to your doctor if any of the above applies to you.
Slovenian: Obvestite svojega zdravnika, če se kar koli od naštetega nanaša na vas.
English: The elevated insulin levels did not persist beyond the time of the meal challenge.
Slovenian: Zvečana koncentracija insulina ni trajala dlje kot izziv z obrokom.
English: Prandin has no direct influence on the ability to drive and use machines but may cause hypoglycaemia.
Slovenian: Zdravilo Prandin nima neposrednega vpliva na sposobnost vožnje in upravljanja s stroji, vendar pa lahko povzroči hipoglikemijo.
English: Repaglinide is eliminated rapidly within 4 - 6 hours from the blood.
Slovenian: Izločanje Repaglinid se iz krvi hitro izloči, v 4 do 6 urah.
English: Your body's response to Prandin may change if you take other medicines, especially these:
Slovenian: Odziv na zdravilo Prandin se lahko spremeni, če jemljete še druga zdravila, še posebej:
English: Repaglinide is a short-acting oral secretagogue.
Slovenian: Repaglinid je kratkodelujoči peroralni sekretagog.
English: Do not use this medicine after the expiry date which is stated on the carton and the blister foil after EXP.
Slovenian: Tega zdravila ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli in foliji pretisnega omota poleg oznake »EXP«.
English: • If you are allergic to repaglinide or any of the other ingredients in this medicine (listed in section 6).
Slovenian: • ste alergični na repaglinid ali katero koli sestavino tega zdravila (navedeno v poglavju 6),
English: If any change of your treatment is necessary contact your doctor first.
Slovenian: Če je potrebna kakršna koli sprememba zdravljenja, se najprej posvetujte s svojim zdravnikom.
English: uncommon (≥1/1,000 to <1/100); rare (≥1/10,000 to <1/1,000); very rare (<1/10,000) and not known
Slovenian: Pogostnost je opredeljena kot: pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
English: If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.
Slovenian: Nosečnost in dojenje Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte s svojim zdravnikom, preden vzamete to zdravilo.
English: If you miss a dose, take the next dose as usual - do not double the dose.
Slovenian: Če ste pozabili vzeti odmerek, naslednji odmerek vzemite kot ponavadi.
English: • If you exercise less than usual.
Slovenian: • če ste telesno manj dejavni kot ponavadi.
English: • Diabetes mellitus type 1, C-peptide negative.
Slovenian: • Sladkorna bolezen tipa 1 (na C-peptid negativna).
English: If you take too many tablets, your blood sugar may become too low, leading to a hypo.
Slovenian: Če vzamete preveč tablet, se vam lahko krvni sladkor preveč zniža, kar lahko vodi do hipe.
English: • The normal starting dose is 0.5 mg before each main meal.
Slovenian: • Običajni začetni odmerek je 0,5 mg pred vsakim glavnim obrokom.
English: Elderly No clinical studies have been conducted in patients >75 years of age.
Slovenian: Klinične študije pri bolnikih, starejših od 75 let, niso bile izvedene.
English: In this case, the dosage of metformin should be maintained and repaglinide administered concomitantly.
Slovenian: V tem primeru je treba odmerjanje metformina ohraniti in sočasno uporabiti še repaglinid.
English: Please ask your doctor whether you can drive a car if you:
Slovenian: Posvetujte se s svojim zdravnikom, če sploh smete voziti ali upravljati s stroji:
English: Periodic monitoring is necessary to detect inadequate lowering of blood glucose at the recommended maximum dose level (i.e. primary failure) and to detect loss of adequate blood glucose-lowering response after an initial period of effectiveness (i.e. secondary failure).
Slovenian: Redno spremljanje je potrebno, da bi odkrili nezadostno znižanje glukoze v krvi ob priporočenem največjem odmerku (tj. primarna odpoved), ali nezadostno znižanje glukoze po uvodnem obdobju učinkovitosti (tj. sekundarna odpoved).
English: • Concomitant use of gemfibrozil (see section 4.5).
Slovenian: • Sočasna uporaba gemfibrozila (glejte poglavje 4.5).
English: When repaglinide is used together with other medicinal products that are mainly secreted by the bile, like repaglinide, any potential interaction should be considered.
Slovenian: Če se repaglinid uporablja z drugimi zdravili, ki se izločajo predvsem z žolčem, tako kot repaglinid, je treba upoštevati morebitne interakcije.
English: • If you take other medicines or suffer from liver or kidney problems (see other sections of 2.
Slovenian: • če uporabljate druga zdravila ali imate težave z jetri ali ledvicami (glejte preostanek poglavja
English: In type 2 diabetic patients, the insulinotropic response to a meal occurred within 30 minutes after an oral dose of repaglinide.
Slovenian: Pri bolnikih s sladkorno boleznijo tipa 2 se je insulinotropni odziv na obrok pojavil v 30 minutah po peroralnem odmerku repaglinida.
English: The dosage should be determined by the physician, according to the patient's requirements.
Slovenian: Začetni odmerek Odmerek mora določiti zdravnik glede na bolnikove potrebe.
English: What Prandin is and what it is used for What you need to know before you take Prandin How to take Prandin
Slovenian: Kaj je zdravilo Prandin in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Prandin Kako jemati zdravilo Prandin
English: Cardiovascular disease Rare
Slovenian: Srčne bolezni kardiovaskularna bolezen redki
English: Prandin with alcohol
Slovenian: Zdravilo Prandin skupaj z alkoholom
English: This phenomenon is known as secondary failure, to distinguish it from primary failure, where the medicinal product is ineffective in an individual patient when first given.
Slovenian: Pojav je poznan kot sekundarna odpoved, za razliko od primarne odpovedi, pri kateri je zdravilo neučinkovito, že ko ga posameznik vzame prvič.
English: ANNEX II A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION D. CONDITIONS OR RESTRICTIONS WITH REGARDS TO SAFE AND EFFECTIVE USE OF THE MEDICINAL PRODUCT
Slovenian: A. IZDELOVALEC, ODGOVOREN ZA SPROŠČANJE SERIJ B. POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE C. DRUGI POGOJI IN ZAHTEVE DOVOLJENJA ZA PROMET Z
English: • Obligation to conduct post-authorisation measures The MAH shall complete, within the stated timeframe, the following measures: Description
Slovenian: • Obveznost izvedbe ukrepov po pridobitvi dovoljenja za promet Imetnik dovoljenja za promet z zdravilom mora v določenem časovnem okvirju izvesti naslednje ukrepe:
English: Substances that inhibit OATP1B1 may likewise have the potential to increase plasma concentrations of repaglinide, as has been shown for ciclosporin (see below).
Slovenian: Učinkovine, ki zavirajo OATP1B1, lahko morda koncentracijo repaglinida v plazmi zvišajo podobno, kot je ugotovljeno za ciklosporin (glejte v nadaljevanju).
English: 30 tablets 90 tablets 120 tablets 270 tablets
Slovenian: 30 tablet 90 tablet 120 tablet 270 tablet
English: • Have few or no warning signs of hypos.
Slovenian: • če se hipe pojavijo z malo ali brez predhodnih opozorilnih znakov.
English: * see section Description of selected adverse reactions below Description of selected adverse reactions
Slovenian: * glejte poglavje Opis izbranih neželenih učinkov v nadaljevanju Opis izbranih neželenih učinkov
English: As hypoglycaemia in this study was avoided through increased calorie intake, a relative overdose may result in an exaggerated glucose-lowering effect with development of hypoglycaemic symptoms (dizziness, sweating, tremor, headache etc.).
Slovenian: Ker so se hipoglikemiji v tej študiji izognili z večjim kaloričnim vnosom, lahko relativno preveliko odmerjanje povzroči čezmerno znižanje glukoze in pojav simptomov hipoglikemije (omotica, znojenje, tremor, glavobol, ipd.).
English: • Salicylates (e.g. aspirin)
Slovenian: • salicilate (npr. aspirin),
English: Four blister pack sizes are available.
Slovenian: Na voljo so štiri velikosti pretisnih omotov.
English: Other medicines and Prandin
Slovenian: Druga zdravila in zdravilo Prandin
English: Do not take more Prandin than your doctor has recommended.
Slovenian: Ne jemljite večjega odmerka zdravila Prandin, kot vam ga je predpisal zdravnik.
English: The warning signs of a hypo may come on suddenly and can include: cold sweat; cool pale skin; headache; rapid heart beat; feeling sick; feeling very hungry; temporary changes in vision; drowsiness; unusual tiredness and weakness; nervousness or tremor; feeling anxious; feeling confused; difficulty in concentrating.
Slovenian: Opozorilni znaki hipe se lahko pojavijo nenadoma in lahko vključujejo: hladno znojenje, hladno in bledo kožo, glavobol, hitro bitje srca, občutek slabosti, hudo lakoto, prehodne spremembe vida, zaspanost, nenavadno utrujenost in šibkost, živčnost ali tresenje, občutek tesnobe, občutek zmedenosti in težave s koncentracijo.
English: Based on in vitro data, repaglinide appears to be a substrate for active hepatic uptake (organic anion transporting protein OATP1B1).
Slovenian: Podatki, pridobljeni in vitro, kažejo, da je repaglinid substrat aktivnega prevzema v jetrih (transportna beljakovina organskih anionov OATP1B1).
English: The amount of Prandin, food or exercise may need to be adjusted.
Slovenian: Morda bo treba prilagoditi odmerek zdravila Prandin, količino zaužite hrane ali stopnjo telesne dejavnosti.
English: Trials investigating the combination with other insulin secretagogues have not been performed.
Slovenian: Preskušanja, ki bi proučila kombinacijo z drugimi sekretagogi insulina, niso bila izvedena.
English: • If you have a hypo that makes you pass out, or a lot of hypos, talk to your doctor.
Slovenian: • Če doživite hipo, zaradi katere se onesvestite, ali doživljate veliko hip, se posvetujte s svojim zdravnikom.
English: • The dose may be adjusted by your doctor by up to 4 mg to be taken immediately before or up to 30 minutes before each main meal.
Slovenian: • Zdravnik lahko odmerek zviša do 4 mg, ki ga vzemite tik pred ali do 30 minut pred glavnimi obroki.
English: Alcohol can change the ability of Prandin to reduce the blood sugar.
Slovenian: Alkohol lahko spremeni sposobnost zdravila Prandin, da zniža koncentracijo krvnega sladkorja.
English: Repaglinide acts through a distinct binding site with a short action on the β-cells.
Slovenian: Repaglinid deluje prek posebnega vezavnega mesta s kratkim delovanjem na celice β.
English: Use of repaglinide in case of secondary failure to insulin secretagogues has not been investigated in clinical trials.
Slovenian: Uporaba repaglinida v primerih sekundarne odpovedi sekretagogov insulina v kliničnih preskušanjih ni bila raziskana.
English: Short-term administration of repaglinide may be sufficient during periods of transient loss of control in type 2 diabetic patients usually controlled well on diet.
Slovenian: Kratkotrajna uporaba repaglinida lahko zadošča v obdobjih prehodne izgube urejenosti sladkorne bolezni tipa 2 pri bolnikih, pri katerih je bolezen ponavadi dobro urejena z dieto.
English: The blood glucose-lowering effect of oral hypoglycaemic medicinal products decreases in many patients over time.
Slovenian: Učinkovitost zniževanja glukoze v krvi s peroralnimi antidiabetiki se pri mnogih bolnikih sčasoma zmanjša.
English: • If the acid level in your blood is raised (diabetic ketoacidosis).
Slovenian: • imate zvišano koncentracijo kislin v krvi (diabetična ketoacidoza),
English: If you stop taking Prandin
Slovenian: Če prenehate jemati zdravilo Prandin
English: The most frequent side effect is hypoglycaemia which may affect up to 1 in 10 patients (see If you get a hypo in section 2).
Slovenian: Hipoglikemija je najpogostejši neželeni učinek, ki se lahko pojavi pri največ 1 od 10 bolnikov (glejte podpoglavje V primeru pojava hipe v poglavju 2).
English: • Hypersensitivity (such as rash, itchy skin, redening of the skin, swelling of the skin)
Slovenian: • preobčutljivost (npr. izpuščaj, srbeča koža, pordelost kože, oteklost kože)
English: Combination with insulin secretagogues
Slovenian: Kombinacija s sekretagogi insulina
English: Repaglinide is given preprandially and is titrated individually to optimise glycaemic control.
Slovenian: Odmerjanje Repaglinid se uporablja predprandialno in ga je treba za optimiranje urejenosti glikemije individualno prilagoditi.
English: Generalised hypersensitivity reactions (e.g. anaphylactic reaction), or immunological reactions such as vasculitis.
Slovenian: Generalizirane preobčutljivostne reakcije (npr. anafilaktična reakcija) ali imunološke reakcije, npr.
English: The recommended maximum starting dose of patients transferred to repaglinide is 1 mg given before main meals.
Slovenian: Priporočeni največji začetni odmerek za bolnike, ki prehajajo na repaglinid, je 1 mg pred glavnimi obroki.
English: If your blood sugar is low or you feel a hypo coming on: eat glucose tablets or a high sugar snack or drink, then rest.
Slovenian: Če se vam krvni sladkor preveč zniža ali začutite pojav hipe, zaužijte tablete glukoze ali prigrizek z veliko sladkorja in nato počivajte.
English: The blister pack (aluminium/aluminium) contains 30, 90, 120 or 270 tablets, respectively.
Slovenian: Pretisni omot (aluminij/aluminij) vsebuje 30, 90, 120 ali 270 tablet.
English: • Nonsteroidal anti-inflammatory drugs (NSAID) (a type of painkillers)
Slovenian: • nesteroidna protivnetna zdravila (NSAID, vrsta zdravil proti bolečinam),